Company invites individual and institutional investors, as well as advisors and analysts, to attend online at VirtualInvestorConferences.com
DUBAI, United Arab Emirates, June 24, 2025 (GLOBE NEWSWIRE) — CS Diagnostics Corp. (OTCQB: CSDX), based in Germany and USA and focused on innovation in Healthcare, today announced that Thomas Fahrhoefer, Chairman of the Group, and Mohammad Essayed, Chief Financial Officer, will present live at the Small Cap Growth Virtual Investor Conference hosted by VirtualInvestorConferences.com, on June 26th, 2025
DATE: June 26th
TIME: 12:30 PM ET
LINK: REGISTER HERE
Available for 1×1 meetings: June 27th to July 1st
This will be a live, interactive online event where investors are invited to ask the company questions in real-time. If attendees are not able to join the event live on the day of the conference, an archived webcast will also be made available after the event.
It is recommended that online investors pre-register and run the online system check to expedite participation and receive event updates.
Learn more about the event at www.virtualinvestorconferences.com.
Recent Company Highlights
- Floated 19 million shares on August 23, 2024.
- Uplifted to OTCQB on November 1, 2024
- Submitted FDA application for CS-Protect Hydrogel on March 12, 2025
- MEDUSA evaluated at USD 513 million on April 22, 2025
About CS Diagnostics Corp.
CS Diagnostic Corp. is a global healthcare innovation company committed to advancing medical diagnostics through innovation and precision technology. With a strong foundation in research and a global vision, the company delivers cutting-edge solutions to meet the evolving needs of the healthcare industry. Its flagship products, CS – Protect Hydrogel and MEDUSA are designed to meet critical unmet needs in patient care and environmental protection.
About Virtual Investor Conferences®
Virtual Investor Conferences (VIC) is the leading proprietary investor conference series that provides an interactive forum for publicly traded companies to seamlessly present directly to investors.
Providing a real-time investor engagement solution, VIC is specifically designed to offer companies more efficient investor access. Replicating the components of an on-site investor conference, VIC offers companies enhanced capabilities to connect with investors, schedule targeted one-on-one meetings and enhance their presentations with dynamic video content. Accelerating the next level of investor engagement, Virtual Investor Conferences delivers leading investor communications to a global network of retail and institutional investors.
CONTACTS:
CS Diagnostics Corp
Mohammad Essayed
Chief Financial Officer
+971 52 861 1930
[email protected]
Virtual Investor Conferences
John M. Viglotti
SVP Corporate Services, Investor Access
OTC Markets Group
(212) 220-2221
[email protected]
